[Boulder, Colorado] – [October 01, 2024] Nephrolytics, a cutting-edge AI-powered cloud platform revolutionizing nephrology care, is excited to announce that it has successfully raised the Seed round. This crucial funding will propel the development and launch of Nephrolytics’ Minimum Viable Product (MVP), aimed at enhancing patient outcomes and transforming the landscape of nephrology through advanced analytics and AI-driven insights.
“This funding marks a major milestone for Nephrolytics as we prepare to bring our innovative solutions to the forefront of nephrology care,” said Tina Gill, MBA, Co-founder and CEO of Nephrolytics. “The journey has been both challenging and rewarding, filled with moments of personal growth and learning. I couldn’t be prouder of our team, especially my incredible co-founders, Fahim Rahim, M.D, MBA, Naeem Rahim, M.D and Ali Nadeem, who have been instrumental in pushing us forward. This is just the beginning, and we are excited to take this next step toward revolutionizing healthcare.”
The MVP launch will be a critical stepping stone in validating the platform’s capabilities. Nephrolytics aims to streamline kidney care through data-driven solutions for clinicians, ensuring patients receive the most timely and accurate treatments.
Fahim Rahim, M.D., MBA, Co-founder and President of Nephrolytics, added, “Our vision at Nephrolytics is to empower clinicians with AI-driven tools that act as their co-pilot in delivering exceptional care. This Seed round not only provides the resources we need to finalize our MVP but also demonstrates the strong confidence that our investors, partners, and advisors have in our mission. With this support, we are well on our way to significantly impacting how nephrology care is delivered.”
With the Seed round funding secured, Nephrolytics is preparing for an upcoming kickoff call with investors, advisors, and strategic partners, as the company continues its mission to redefine nephrology care and support clinicians with state-of-the-art AI technology.
About Nephrolytics
Nephrolytics is an AI-powered cloud platform focused on transforming the future of nephrology care. By leveraging advanced analytics and machine learning, Nephrolytics provides real-time insights to clinicians, empowering them to make data-driven decisions that enhance patient outcomes. The platform aims to bridge the gap between technology and healthcare, optimizing treatment plans and improving the quality of care for patients with kidney disease.
For inquiries, please contact: hasan@nephrolytics.ai
Hasan Ayub
SVP of Business Development
hasan@nephrolytics.ai
+ 1 208-991-9170
www.nephrolytics.ai
